As of Sep 24
| -0.85 / -1.07%|
The 22 analysts offering 12-month price forecasts for CVS Health Corp have a median target of 86.00, with a high estimate of 100.00 and a low estimate of 70.00. The median estimate represents a +9.22% increase from the last price of 78.74.
The current consensus among 24 polled investment analysts is to Buy stock in CVS Health Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.